Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tikun Olam cannabis oil
- Development stage
- Discontinued
- Lead developer
- Tikun Olam
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tikun Olam cannabis oil is a botanical drug product developed by the Israeli company Tikun Olam. It is a standardized cannabinoid-containing oil formulation designed to modulate appetite and nutritional status, primarily through the activation of endocannabinoid receptors CB1 and CB2. The product has been investigated in Phase 3 clinical trials for the treatment of protein-energy malnutrition and appetite disorders in patients undergoing hemodialysis. While the company produces various specific strains (such as Avidekel and Alaska), the lead 'Cannabis Oil' program specifically targeted nutritional support in chronic disease states. The Phase 3 trial for malnutrition was subsequently withdrawn.
- Brand names
- Tikun Olam
- Other names
- Cannabis Oil
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Tikun Olam cannabis oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tikun Olam cannabis oil.